Myeloproliferative Neoplasms

The OncLive Myeloproliferative Neoplasms condition center is a comprehensive resource for clinical news and expert insights on myeloproliferative neoplasms, including myelofibrosis, polycythemia vera, and essential thrombocythemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in myeloproliferative neoplasms.

Latest News

EMA Accepts MMA for Momelotinib in Myelofibrosis
EMA Accepts MMA for Momelotinib in Myelofibrosis

December 2nd 2022

The European Medicines Agency has accepted a marketing authorization application for momelotinib as a treatment for patients with myelofibrosis.

Expanding Treatment Options Elevate Outcomes for Patients With Myelofibrosis
Expanding Treatment Options Elevate Outcomes for Patients With Myelofibrosis

November 28th 2022

Innovations Are Poised to Lead MPN/MDS Treatment Landscape in a Positive Direction
Innovations Are Poised to Lead MPN/MDS Treatment Landscape in a Positive Direction

November 9th 2022

Azacitidine-Based Combinations Represent New Treatment Possibilities in MDS
Azacitidine-Based Combinations Represent New Treatment Possibilities in MDS

November 2nd 2022

European Commission Grants Orphan Drug Designation to Selinexor for Myelofibrosis
European Commission Grants Orphan Drug Designation to Selinexor for Myelofibrosis

November 1st 2022

Video Series
Video Interviews
Podcasts

More News